Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
AGADA Biosciences
h-index: 10
Total citations: 498
Total papers: 33
Homepage:
http://www.agadabio.com/
Recent papers from AGADA Biosciences
Neurodevelopmental disease-causing variants in choline kinase CHKA gene couple phosphatidylcholine synthesis to oxidative stress damage and disease etiology
Journal of Biological Chemistry · 2025
The effect of IL-1β inhibitor canakinumab (Ilaris®) on IL-6 production in human skeletal muscle cells
PLoS ONE · 2025
Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis
Frontiers in Immunology · 2025
High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophy
Biology Open · 2024
Loss of Dnajc21 leads to cytopenia and altered nucleotide metabolism in zebrafish
Leukemia · 2024
Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation
JCI Insight · 2022
Mechanism of action and therapeutic route for a muscular dystrophy caused by a genetic defect in lipid metabolism
Nature Communications · 2022
A mouse model of inherited choline kinase β-deficiency presents with specific cardiac abnormalities and a predisposition to arrhythmia
Journal of Biological Chemistry · 2022
Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice
PLoS ONE · 2021
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
JAMA Neurology · 2020
Genetic tool development in marine protists: emerging model organisms for experimental cell biology
Nature Methods · 2020
Orthogonal Analysis of Dystrophin Protein and Mrna As A Surrogate Outcome for Drug Development
Biomarkers in Medicine · 2019
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy
Life Science Alliance · 2019
Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration
Breast Cancer Research · 2018
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin‐deficient mdx mice: proof‐of‐concept study and independent validation of efficacy
The FASEB Journal · 2017
Tyrosine kinase-mediated axial motility of basal cells revealed by intravital imaging
Nature Communications · 2016